– Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for the Study of the Liver Congress 2024 –
– Two additional hepatitis program data readouts.
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 2,500,000 shares, a drop of 10.7% from the March 31st total of 2,800,000 shares. Based on an average daily volume of 836,100 shares, […]
President Biden signed the Inflation Reduction Act (IRA) into law on Aug. 16, 2022, with the goal of reducing health care costs for the government and participants in Medicare and.
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Free Report) is scheduled to issue its quarterly earnings data before the market opens on Thursday, May 2nd. Analysts expect the company to announce earnings of ($0.75) per share for the quarter. Parties that are interested in participating in the company’s conference call can do so using this link. Alnylam […]